Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
for Duchenne Muscular Dystrophy (DMD)
1 location in Hillsborough
Sponsor: Dyne Therapeutics
Sex: Male·Age: 4 - 18
Code: NCT07608432·Phase 3·Recruiting·Listed May 27, 2026